Correlation between Blood Type 0 and Risk of Chronic Subdural Hematoma Recurrence: A Single Center Retrospective Cohort Study.
ABO blood type
chronic subdural hematoma
minor head trauma
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
28 Mar 2023
28 Mar 2023
Historique:
received:
09
03
2023
revised:
22
03
2023
accepted:
24
03
2023
medline:
16
5
2023
pubmed:
16
5
2023
entrez:
16
5
2023
Statut:
epublish
Résumé
Chronic subdural hematoma (cSDH) is a common disease in the neurological and neurosurgical world. The recommended treatment for cSDH patients with moderate or severe neurological symptoms is surgical evacuation, but cSDH frequently recurs. The patient's ABO blood type may influence the outcome. This study aims to evaluate the correlation between cSDH recurrence and blood type O. We performed a retrospective analysis of the data of patients with cSDH who were surgically treated. Recurrence was defined as the need for re-operation within the first 12 weeks after the initial surgery. We analyzed standard demographic data, duration and type of surgery, ABO blood types, and the re-operation rate. Univariate and multivariate analyses were conducted. A total of 229 patients were included. The recurrence of hematoma was identified in 20.5% of patients. Blood type O was found to be significantly associated with cSDH recurrence leading to re-operation within 12 weeks (
Identifiants
pubmed: 37190532
pii: brainsci13040567
doi: 10.3390/brainsci13040567
pmc: PMC10137021
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Front Neurol. 2022 May 20;13:833958
pubmed: 35669879
Neurol Med Chir (Tokyo). 2015;55(2):173-8
pubmed: 25746312
Risk Manag Healthc Policy. 2019 Nov 01;12:179-188
pubmed: 31802959
Blood Adv. 2020 Oct 27;4(20):5157-5164
pubmed: 33095871
Rev Neurol. 2014 Oct 1;59(7):294-300
pubmed: 25245873
Brain Res. 2015 Nov 2;1625:84-96
pubmed: 26315377
Neurosurg Rev. 2022 Aug;45(4):2777-2786
pubmed: 35461433
Clin Neurol Neurosurg. 2015 Nov;138:66-71
pubmed: 26282910
PLoS One. 2018 Oct 4;13(10):e0204331
pubmed: 30286106
Clin Neurol Neurosurg. 2013 Jul;115(7):981-4
pubmed: 23128014
J Neurosurg. 2018 Jan;128(1):222-228
pubmed: 28156246
Korean J Neurotrauma. 2014 Apr;10(1):15-21
pubmed: 27169027
J Thromb Thrombolysis. 2013 Jan;35(1):65-6
pubmed: 22886406
J Thromb Haemost. 2013 Jan;11(1):187-9
pubmed: 23137307
Acta Neurochir (Wien). 2018 Apr;160(4):761-766
pubmed: 29455413
J Neurosurg. 2021 Jan 01;135(4):1203-1207
pubmed: 33385994
J Neurotrauma. 2021 Jul 15;38(14):1979-1987
pubmed: 33497585
Clin Neurol Neurosurg. 2020 Apr;191:105705
pubmed: 32035359
QJM. 2017 Jun 01;110(6):375-378
pubmed: 28069915
Acta Neurochir (Wien). 2020 Sep;162(9):2033-2043
pubmed: 32524244
Brain Inj. 2012;26(13-14):1731-6
pubmed: 22759238
Blood. 2020 Dec 17;136(25):2864-2874
pubmed: 32785650
Korean J Neurotrauma. 2015 Oct;11(2):75-80
pubmed: 27169069
Zentralbl Neurochir. 2008 Aug;69(3):129-33
pubmed: 18666056
Front Neurol. 2019 Apr 05;10:311
pubmed: 31024417
Transfusion. 2001 Jan;41(1):56-60
pubmed: 11161246
Int J Immunogenet. 2019 Apr;46(2):67-73
pubmed: 30604500
Br J Haematol. 1964 Apr;10:238-45
pubmed: 14141622